Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity (2020 - 2026)

Biodesix filings provide 7 years of Return on Equity readings, the most recent being 0.1% for Q1 2026.

  • On a quarterly basis, Return on Equity fell 7.0% to 0.1% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.1%, a 7.0% decrease, with the full-year FY2025 number at 0.04%, down 1.0% from a year prior.
  • Return on Equity hit 0.1% in Q1 2026 for Biodesix, down from 0.17% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.37% in Q3 2025 to a low of 0.32% in Q4 2023.
  • Median Return on Equity over the past 5 years was 0.03% (2024), compared with a mean of 0.13%.
  • The widest YoY moves for Return on Equity: up 138bps in 2025, down -102bps in 2025.
  • Biodesix's Return on Equity stood at 0.07% in 2022, then crashed by -390bps to 0.32% in 2023, then surged by 95bps to 0.02% in 2024, then soared by 1069bps to 0.17% in 2025, then tumbled by -158bps to 0.1% in 2026.
  • The last three reported values for Return on Equity were 0.1% (Q1 2026), 0.17% (Q4 2025), and 1.37% (Q3 2025) per Business Quant data.